BlueCrest Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-6,465
| Closed | -$1.98M | – | 464 |
|
|
2019
Q1 | $1.98M | Buy |
+6,465
| New | +$1.98M | 0.08% | 172 |
|
|
2018
Q4 | – | Sell |
-2,633
| Closed | -$824K | – | 882 |
|
|
2018
Q3 | $824K | Sell |
2,633
-548
| -17% | -$171K | 0.02% | 510 |
|
|
2018
Q2 | $918K | Sell |
3,181
-71,526
| -96% | -$20.6M | 0.02% | 532 |
|
|
2018
Q1 | $18.7M | Sell |
74,707
-38,205
| -34% | -$9.55M | 0.58% | 17 |
|
|
2017
Q4 | $26.9M | Buy |
112,912
+40,347
| +56% | +$9.63M | 0.73% | 11 |
|
|
2017
Q3 | $16.1M | Sell |
72,565
-59,286
| -45% | -$13.2M | 0.66% | 23 |
|
|
2017
Q2 | $29.8M | Sell |
131,851
-56,021
| -30% | -$12.7M | 1.16% | 3 |
|
|
2017
Q1 | $37.5M | Buy |
187,872
+121,602
| +183% | +$24.2M | 1.77% | 1 |
|
|
2016
Q4 | $12.1M | Buy |
66,270
+64,427
| +3,496% | +$11.7M | 0.66% | 20 |
|
|
2016
Q3 | $302K | Buy |
+1,843
| New | +$302K | 0.01% | 577 |
|
|
2016
Q2 | – | Sell |
-9,190
| Closed | -$1.26M | – | 816 |
|
|
2016
Q1 | $1.26M | Buy |
+9,190
| New | +$1.26M | 0.08% | 294 |
|